Increased levothyroxine requirements presenting as 'inappropriate' TSH secretion syndrome in a patient with nephrotic syndrome

Journal of Endocrinological Investigation

Volumn 23, Issue 6, 2000, Pages 383-392

  Collins, M T ^b   Remaley, A T ^b   Csako, G ^b   Pucino, F ^b   Skarulis, M C ^b   Balow, J E ^b   Sarlis, Nicholas J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Building #10 ^*

Author keywords

'Inappropriate' TSH secretion; Hypothyroidism; Levothyroxine; Nephrotic syndrome; Proteinuria

Indexed keywords

ATORVASTATIN; CYCLOSPORIN; FUROSEMIDE; IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; METOLAZONE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; EDEMA; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LIOTHYRONINE BLOOD LEVEL; MALE; NEPHROTIC SYNDROME; PROTEINURIA; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; URINARY EXCRETION;

EID: 0033919482     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343742     Document Type: Article

References (74)

1. Eddy A.A., Schnaper H.W. The nephrotic syndrome: from the simple to the complex. Semin. Nephrol. 1998, 18: 304-316.
2. Peters J.P., Man E.B. The relation of albumin to precipitable iodine of serum. J. Clin. Invest. 1948, 27: 397-406.
3. Robbins J., Rall J.E., Petermann M.L. Thyroxine binding by serum and urine proteins in nephrosis. Qualitative aspects. J. Clin. Invest. 1957, 36: 1333-1338.
4. Recant L., Rigg D.S. Thyroid function in nephrosis. J. Clin. Invest. 1952, 31: 789-799.
5. Musa B.U., Seal U.S., Doe R.P. Excretion of corticosteroid-binding globulin, thyroxine-binding globulin and total protein in adult males with nephrosis: effects of sex hormones. J. Clin. Endocrinol. 1967, 27: 768-774.
6. Rasmussen H., Rapp B. Thyroxine metabolism in the nephrotic syndrome. J. Clin. Invest. 1956, 35: 792-798.
7. Börner E., Kammenhuber K., Meissner H.P. Renal loss of thyroxine in nephrotic syndrome. Klin. Wochenschr. 1970, 48: 1320-1322.
8. Burke C.W., Shakespear R.A. Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein. J. Clin. Endocrinol. Metab. 1976, 42: 504-513.
9. Etling N., Fouqué F. Effect of prednisone on serum and urinary thyroid hormone levels in children during the nephrotic syndrome. Helv. Paediatr. Acta 1982, 37: 257-265.
10. Adlkofer F., Hain H., Meinhold H., Kraft D., Ramsden D., Herrmann J., Heller W.D. Thyroid function in patients with proteinuria and normal or increased serum creatinine concentration. Acta Endocrinol. 1983, 102: 367-376.
11. Orden I., Pie J., Juste M.G., Giner A., Gomez M.E., Escanero J.F. Urinary triiodothyronine excretion. Rev. Esp. Fisiol. 1988, 44: 179-184.
12. Afrasiabi M.A., Vaziri N.D., Gwinup G., Mays D.M., Barton C.H., Ness R.L., Valenta L.J. Thyroid function studies in the nephrotic syndrome. Ann. Intern. Med. 1979, 90: 335-338.
13. Ito S., Kano K., Ando T., Ichimura T. Thyroid function in children with nephrotic syndrome. Pediatr. Nephrol. 1994, 8: 412-415.
14. Fonseca V., Thomas M., Katrak A., Sweny P., Moorhead J.F. Can urinary thyroid hormone loss cause hypothyroidism? Lancet 1991, 338: 475-476.
15. Yoshida K., Sakurada T., Kaise K., Kaise N., Nomura T., Itagaki Y., Yamamoto M., Saito S., Yoshinaga K. Measurement of thyroid stimulating hormone (TSH) in human urine. Endocrinol. Jpn. 1988, 35: 733-739.
16. Kaptein E.M., Hoopes M.T., Parise M., Massry S.G. rT3 metabolism in patients with nephrotic syndrome and normal GFR compared with normal subjects. Am. J. Physiol. 1991, 260: E641-E650.
17. Vaziri N.D. Endocrinological consequences of the nephrotic syndrome. Am. J. Nephrol. 1993, 13: 360-364.
18. Gavin L.A., McMahon F.A., Castle J.N., Cavalieri R.R. Alterations in serum thyroid hormones and thyroxine-binding globulin in patients with nephrosis. J. Clin. Endocrinol. Metab. 1978, 46: 125-130.
19. Liappis N., Rao G.S. Behavior of the levels of free triiodothyronine, triiodothyronine, free thyroxine, thyroxine, thyrotropin and thyroxin-binding globulin in serum of children with nephrotic syndrome. Klin. Padiatr. 1985, 197: 423-426.
20. Mattoo T.K. Hypothyroidism in infants with nephrotic syndrome. Pediatr. Nephrol. 1994, 8: 657-659.
21. Johnson V., New M.I. If the stimulus to pituitary thyroid-stimulating hormone (TSH) secretion is the lack of circulating free thyroxine (free-T4) why may a baby with congenital nephrotic syndrome present with a raised TSH on neonatal screening? Pediatr. Nephrol. 1992, 6: 458. Comment by Vargas A. Pediatr. Nephrol. 1992, 6: 469.
22. Johnson V., New M.I. If the stimulus to pituitary thyroid-stimulating hormone (TSH) secretion is the lack of circulating free thyroxine (free-T4) why may a baby with congenital nephrotic syndrome present with a raised TSH on neonatal screening? Pediatr. Nephrol. 1992, 6: 458. Comment by Vargas A. Pediatr. Nephrol. 1992, 6: 469.
23. De Luca F., Gemelli M., Pandullo E., Barberio G., Benvenga S., Trimarchi F. Changes in thyroid function tests in infantile nephrotic syndrome. Horm. Metab. Res. 1983, 15: 258-259.
24. McLean R.H., Kennedy T.L., Rosoulpour M., Ratzan S.K., Siegel N.J., Kauschansky A., Genel M. Hypothyroidism in the congenital nephrotic syndrome. J. Pediatr. 1982, 101: 72-75.
25. Warady B.A., Howard C.P., Hellerstein S., Alon U., Grune J.A. Congenital nephrosis in association with hypothyroidism and hypoadrenocorticism. Pediatr. Nephrol. 1993, 7: 79-80.
26. th Ann. Mtg. Endocr. Soc., New Orleans, LA, 1998, P3-610, p. 510 [Abstract].
27. Ebert C., Bieglmayer C., Igari J., Chan D., Torralba A., Muller C., Veys A., Batz O., Dageforde S., Roth H.J., Neumeier D., Assmann G., Banfi G.M., Yvert J.P. Elecsys TSH, FT4, T4, T-uptake, FT3 and T3. Clinical results of a multicentre study. Wien. Klin. Wochenschr. 1998, 3 (Suppl.): 27-40.
28. Forest J.C., Masse J., Lane A. Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer. Clin. Biochem. 1998, 31: 81-88.
29. Sapin R., Gasser F., d'Herbomez M., Wemeau J.L., Ebert C., Schlienger J.L. Elecsys thyrotropin (TSH) assay evaluated. Clin. Chem. 1997, 43: 545-547.
30. Luppa P.B., Reutemann S., Huber U., Hoermann R., Poertl S., Kraiss S., von Bulow S., Neumeier D. Pre-evaluation and system optimization of the Elecsys thyroid electrochemiluminescence immunoassays. Clin. Chem. Lab. Med. 1998, 36: 789-796.
31. Sapin R., Schlienger J.L., Goichot B., Gasser F., Grucker D. Evaluation of Elecsys free triiodothyronine assay: relevance of age-related reference ranges. Clin. Biochem. 1998, 31: 399-404.
32. Nelson J.C., Tomei R.T. Direct determination of free thyroxine in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin. Chem. 1988, 34: 1737-1744.
33. Anonymous. T3 Package Insert. Ciba-Corning Diagnostics Corp. East Walpole, MA, 1992.
34. Hays M.T. Thyroid hormone and the gut. Endocr. Res. 1988, 14: 203-224.
35. Ain K.B., Refetoff S., Fein H.G., Weintraub B.D. Pseudomalabsorption of levothyroxine. JAMA 1991, 266: 2118-2120.
36. Vanhaelst L., Van Cauter E., Degaute J.P., Golstein J. Circadian variations of serum thyrotropin levels in man. J. Clin. Endocrinol. Metab. 1972, 35: 479-482.
37. Farmer J.A., Gotto A.M. Jr. Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf. 1994, 11: 301-309.
38. Smith P.F., Grossman S.J., Gerson R.J., Gordon L.R., Deluca J.G., Majka J.A., Wang R.W., Germershausen J.I., MacDonald J.S. Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat. Toxicol. Pathol. 1991, 19: 197-205.
39. Newnham H.H., Hamblin P.S., Long F., Lim C.F., Topliss D.J., Stockigt J.R. Effect of oral frusemide on diagnostic indices of thyroid function. Clin. Endocrinol. (Oxf.) 1987, 26: 423-431.
40. Munro S.L., Lim C.F., Hall J.G., Barlow J.W., Craik D.J., Topliss D.J., Stockigt J.R. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 1989, 68: 1141-1147.
41. Sapin R., Gasser F., Schlienger J.L. Familial dysalbuminemic hyperthyroxinemia and thyroid hormone autoantibodies: interference in current free thyroid hormone assays. Horm. Res. 1996, 45: 139-141.
42. Raines K.B., Baker J.R. Jr., Lukes Y.G., Wartofsky L., Burman K.D. Antithyrotropin antibodies in the sera of Graves' disease patients. J. Clin. Endocrinol. Metab. 1985, 61: 217-222.
43. Kahn B.B., Weintraub B.D., Csako G., Zweig M.H. Factitious elevation of thyrotropin in a new ultrasensitive assay: implications for the use of monoclonal antibodies in "sandwich" immunoassay. J. Clin. Endocrinol. Metab. 1988, 66: 526-533.
44. Zweig M.H., Csako G., Benson C.C., Weintraub B.D., Kahn B.B. Interference by anti-immunoglobulin G antibodies in immunoradiometric assays of thyrotropin involving mouse monoclonal antibodies. Clin. Chem. 1987, 33: 840-844.
45. Csako G., Weintraub B.D., Zweig M.H. The potency of immunoglobulin G fragments for inhibition of interference caused by anti-immunoglobulin antibodies in a monoclonal immunoradiometric assay for thyrotropin. Clin. Chem. 1988, 34: 1481-1483.
46. Anonymous. Levothyroxine sodium tablets. USP 23/NF 18. In: The United States Pharmacopeia. The United States Pharmacopeial Convention, Inc., Rockville, MD, 1995, p. 884.
47. Sapin R., Schlienger J.L., Kaltenbach G., Gasser F., Christofides N., Roui G., Gervais A., Petitjean P., Chambron J. Determination of free triiodothyronine by six different methods in patients with non-thyroidal illness and in patients treated with amiodarone. Ann. Clin. Biochem. 1995, 32: 314-324.
48. Beck-Peccoz P., Persani L. Variable biological activity of thyroid-stimulating hormone. Eur. J. Endocrinol. 1994, 131: 331-340.
49. Brucker-Davis F., Skarulis M.C., Grace M.B., Benichou J., Hauser P., Wiggs E., Weintraub B.D. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann. Intern. Med. 1995, 123: 572-583.
50. Brucker-Davis F., Oldfield E.H., Skarulis M.C., Doppman J.L., Weintraub B.D. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J. Clin. Endocrinol. Metab. 1999, 84: 476-486.
51. th Ann. Mtg. Endocr. Soc., Washington, DC, 1995, P1-396, p. 211. [Abstract].
52. Beck-Peccoz P., Persani L., Faglia G. Glycoprotein hormone a-subunit in pituitary adenomas. Trends Endocrinol. Metab. 1992, 3: 41-46.
53. Beck-Peccoz P., Forloni F., Cortelazzi D., Persani L., Papandreou M.J., Asteria C., Faglia G. Pituitary resistance to thyroid hormones. Horm. Res. 1992, 38: 66-72.
54. McDermott M.T., Ridgway E.C Thyroid hormone resistance syndromes. Am. J. Med. 1993, 94: 424-432.
55. Beck-Peccoz P., Roncoroni R., Mariotti S., Medri G., Marcocci C., Brabant G., Forloni F., Pinchera A., Faglia G. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in non-neoplastic IST. J. Clin. Endocrinol. Metab. 1990, 71: 19-25.
56. Shakespear R.A., Burke C.W. Triiodothyronine and thyroxine in urine. I. Measurement and application. J. Clin. Endocrinol. Metab. 1976, 42: 494-503.
57. Gaitan J.E., Wahner H.W., Gorman C.A., Jiang N.S. Measurement of triiodothyronine in unextracted urine. J. Lab. Clin. Med. 1975, 86: 538-546.
58. Horvath F. Jr., Teague P., Gaffney E.F., Mars D.R., Fuller T.J. Thyroid antigen associated immune complex glomerulonephritis in Graves' disease. Am. J. Med. 1979, 67: 901-904.
59. Sato Y., Sasaki M., Kan R., Osaku A., Koyama S., Shibayama S., Sato M., Narumiya K., Takagi T., Kojima M., et al. Thyroid antigen-associated glomerulonephritis in Graves' disease. Clin. Nephrol. 1989, 31: 49-52.
60. Ritz E. Simultaneous relapse of minimal-change glomerulonephritis and Graves'disease. Nephrol. Dial. Transplant. 1997, 12: 1541.
61. Tanemoto M., Miyakawa H., Hanai J., Yago M., Kitaoka M., Uchida S. Myeloperoxidase-antineutrophilic cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves'disease: report of three adult cases. Am. J. Kidney Dis. 1995, 26: 774-780.
62. Pillinger M., Staud R. Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease. Semin. Arthritis Rheum. 1998, 28: 124-129.
63. Reynolds L.R., Bhathena D. Nephrotic syndrome associated with methimazole therapy. Arch. Intern. Med. 1979, 139: 236-237.
64. Jones B.M., Cheng I.K., Wong R.W., Kung A.W. CD5-positive and CD5-negative rheumatoid factor-secreting B cells in IgA nephropathy, rheumatoid arthritis and Graves' disease. Scand. J. Immunol. 1993, 38: 575-580.
65. Mclver B., Gorman C.A. Euthyroid sick syndrome: an overview. Thyroid 1997, 7: 125-132.
66. Chadha V., Alon U.S. Bilateral nephrectomy reverses hypothyroidism in congenital nephrotic syndrome. Pediatr. Nephrol. 1999, 13: 209-211.
67. Kano K., Ito S., Ichimura T. Effect of prednisone on thyroid function in children with nephrotic syndrome. Horm. Metab. Res. 1994, 26: 395-396.
68. Carpi A., Romano F., Massitelli M., Ciardella F. Low protein supplemented diet corrects altered serum thyroid hormone and TSH concentrations in patients with chronic nephrotic syndrome. Thyroidology 1990, 2: 89-95.
69. St. Germain D.L., Adler R.A., Galton V.A. Thyroxine 5′-deiodinase activity in anterior pituitary glands transplanted under the renal capsule in the rat. Endocrinology 1985, 117: 55-63.
70. Lechan R.M., Kakucska I. Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus. Ciba Found. Symp. 1992, 168: 144-158.
71. Tu H.M., Kim S.W., Salvatore D., Bartha T., Legradi G., Larsen P.R., Lechan R.M. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 1997, 138: 3359-3368.
72. Glass A.R., Vigersky R.A., Rajatanavin R., Pardridge W., Smallridge R.C., Wartofsky L., Burman K.D. Low serum thyroxine and high serum triiodothyronine in nephrotic rats: etiology and implications for bioavailability of protein-bound hormone. Endocrinology 1984, 114: 1745-1753.
73. Benvenga S., Sobbrio G.A., Vermiglio F., Li Calzi L., Cannavo S., Consolo F., Trimarchi F. Abnormal daily periodicity of serum thyrotropin (TSH) and evidence for defective TSH suppression in a case of non-neoplastic syndrome of inappropriate TSH secretion. J. Endocrinol. Invest. 1987, 10: 195-202.
74. Bartolone L., Regalbuto C., Benvenga S., Filetti S., Trimarchi F., Pontecorvi A. Three new mutations of thyroid hormone receptorbeta associated with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 1994, 79: 323-326.